| Followers | 1106 |
| Posts | 279775 |
| Boards Moderated | 10 |
| Alias Born | 03/18/2011 |
Sunday, February 26, 2012 7:55:40 AM
IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology and skin conditions in dermatology (also referred to as aesthetics). Its ophthalmology products consist of laser systems, delivery devices and consumable instrumentation, including laser probes and are used in the treatment of serious eye diseases. In addition, the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation. In February 2012, Cutera, Inc. acquired certain assets of the Company's IRIDEX' aesthetic business unit.
http://www.google.com/finance?q=IRIX
http://www.google.com/finance?q=IRIX
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent IRIX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 03:40:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/19/2026 08:16:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 08:13:42 PM
- Iridex Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/19/2026 08:05:00 PM
- Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 • GlobeNewswire Inc. • 05/05/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/24/2026 08:09:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 08:06:54 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:05:04 PM
- Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology • GlobeNewswire Inc. • 04/07/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 05:55:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:22:19 PM
- Iridex Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:16:13 PM
- Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026 • GlobeNewswire Inc. • 03/12/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 05:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 05:55:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/10/2026 08:19:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 11:21:19 PM
- Iridex Announces Plans to Relocate Headquarters • GlobeNewswire Inc. • 02/02/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2026 08:58:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 06:13:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 06:14:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 03:22:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 07:48:16 PM
